ESLA Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-2640001996255-26-000004SEC →
2026-08-2540001213900-26-093698SEC →
2026-08-218-K0001213900-26-092657SEC →
2026-08-14SCHEDULE 13G/A0001172661-26-003573SEC →
2026-08-1310-Q0001213900-26-089215SEC →
2026-06-308-K0001213900-26-073847SEC →
2026-05-27DEF 14A0001140361-26-023012SEC →
2026-05-1810-Q0001213900-26-058063SEC →
2026-05-18NT 10-Q0001213900-26-058062SEC →
2026-05-15SCHEDULE 13G0001172661-26-002144SEC →
2026-04-3010-K/A0001213900-26-050433SEC →
2026-04-2940001213900-26-049602SEC →
2026-03-1810-K0001213900-26-029357SEC →
2026-02-13424B30001213900-26-016605SEC →
2026-01-23EFFECT9999999995-26-000279SEC →
2026-01-22CORRESP0001213900-26-006650SEC →
2026-01-22S-1/A0001213900-26-006410SEC →
2026-01-16S-1/A0001213900-26-005233SEC →
2026-01-138-K0001213900-26-003998SEC →
2026-01-068-K0001213900-26-001777SEC →
2026-01-06424B50001213900-26-001686SEC →
2025-12-29UPLOAD0000000000-25-011874SEC →
2025-12-22S-10001213900-25-124247SEC →
2025-12-048-K0001213900-25-118097SEC →
2025-11-1210-Q0001213900-25-109198SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Estrella Immunopharma (ESLA) — Filings